OFFICIAL PUBLICATION OF

pdl.com.au

by its subsidiary APPco

Ellura recall

Megan Haggan 14/02/2022

page that reads "product recall"

A batch of Ellura capsules has been recalled due to the presence of ethylene oxide The TGA has announced that in consultation with SFI Australasia, it has initiated a recall for one batch of the capsules, used to support urinary tract health. The affected batch is N0121301 (expiry 01/2024). It was first sold into the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart